Home
>
National Drug Code (NDC)
>
Rhophylac
Rhophylac - 44206-300-01 - (HUMAN RHO(D) IMMUNE GLOBULIN)
Drug Information of Rhophylac
| Product NDC: | 44206-300 |
| Proprietary Name: | Rhophylac |
| Non Proprietary Name: | HUMAN RHO(D) IMMUNE GLOBULIN |
| Active Ingredient(s): | 1500 [iU]/2mL & nbsp; HUMAN RHO(D) IMMUNE GLOBULIN |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Rhophylac
| Product NDC: | 44206-300 |
| Labeler Name: | CSL Behring AG |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125070 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090106 |
Package Information of Rhophylac
| Package NDC: | 44206-300-01 |
| Package Description: | 1 SYRINGE, GLASS in 1 CARTON (44206-300-01) > 2 mL in 1 SYRINGE, GLASS (44206-300-90) |
NDC Information of Rhophylac
| NDC Code | 44206-300-01 |
| Proprietary Name | Rhophylac |
| Package Description | 1 SYRINGE, GLASS in 1 CARTON (44206-300-01) > 2 mL in 1 SYRINGE, GLASS (44206-300-90) |
| Product NDC | 44206-300 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | HUMAN RHO(D) IMMUNE GLOBULIN |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20090106 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring AG |
| Substance Name | HUMAN RHO(D) IMMUNE GLOBULIN |
| Strength Number | 1500 |
| Strength Unit | [iU]/2mL |
| Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
